Stocks
Theravance Biopharma, Inc.TBPH
NASDAQHealthcareBiotechnology$13.78-0.79%
Focused on developing organ-selective medicines, this biopharmaceutical company specializes in treatments for inflammatory and fibrotic diseases. Investors monitor its pipeline, including late-stage candidates for lung and gastrointestinal disorders, given its potential in niche therapeutic areas.
Market Cap: $698.3M52W Range: $7.90 – $21.03
Congressional Interest in Theravance Biopharma, Inc. (TBPH)
1 member of Congress has disclosed 1 trade in Theravance Biopharma, Inc. (TBPH), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading TBPH?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-03-24 | George Whitesides | sell | $15K – $50K |